NS Pharma's Leadership Change: Fostering Innovation in Rare Disease Therapies NS Pharma announces new leadership in its Commercial division aimed at enhancing growth in rare disease therapies, including VILTEPSO.

NS Pharma's Leadership Change: Fostering Innovation in Rare Disease Therapies #USA #NS_Pharma #VILTEPSO #Donald_Foy #Paramus